The Center for Biotechnology (BTC) at Khalifa University is a multidisciplinary research center dedicated to advancing scientific discovery, technological innovation, and translational research to address some of the most pressing challenges in human health and population wellbeing. By integrating fundamental biological sciences, advanced engineering, computational technologies, clinical research, and population health, BTC aims to develop innovative solutions that improve disease prevention, diagnosis, treatment, and long-term health outcomes.
Our vision is to establish BTC as a leading regional and internationally recognized center of excellence in biotechnology, where scientific discoveries are translated into meaningful advances in precision healthcare, innovative therapeutics, disease prevention, and sustainable population health. We aspire to contribute to a future in which biotechnology, artificial intelligence, and data-driven scientific approaches enable healthier, longer, and more productive lives.
Our mission is to generate impactful scientific knowledge, accelerate the translation of research discoveries into clinical and societal applications, and strengthen the biotechnology innovation ecosystem in the United Arab Emirates and internationally. Through interdisciplinary collaboration, advanced research infrastructure, strategic partnerships, and the development of highly skilled scientific talent, BTC seeks to bridge the gap between fundamental research and real-world healthcare solutions.
Our activities are guided by a commitment to scientific excellence and integrity, responsible innovation, interdisciplinary collaboration, knowledge exchange, societal impact, and sustainability. These principles underpin our ambition to contribute to the UAE鈥檚 national priorities in healthcare innovation, advanced technologies, scientific capacity building, and economic diversification.
BTC鈥檚 research strategy is organized around three complementary and interconnected themes, designed to address the continuum from molecular discovery and technological development to clinical translation, disease prevention, and population wellbeing.
This theme focuses on transforming healthcare through the integration of advanced biological data, artificial intelligence, computational sciences, and digital technologies. By combining genomics, transcriptomics, proteomics, metabolomics, and other multi-omics approaches with electronic health records, clinical information, and real-world health data, our researchers seek to understand the biological and environmental determinants of disease and develop more accurate, personalized approaches to healthcare.
Research priorities include:
Particular emphasis is placed on understanding complex and multifactorial diseases, identifying population-specific risk factors, discovering clinically relevant biomarkers, and supporting the transition from reactive healthcare toward predictive, preventive, personalized, and data-driven medicine.
Through collaborations involving clinicians, biologists, engineers, bioinformaticians, statisticians, and data scientists, this theme aims to translate large-scale biological and clinical information into actionable knowledge that can support healthcare professionals, patients, and health systems.
This theme is dedicated to accelerating the discovery, development, and clinical translation of innovative diagnostics, therapeutics, and biomedical technologies. It brings together molecular and cellular biology, computational drug discovery, advanced disease modeling, biomaterials, and clinical research to address unmet medical needs and improve treatment outcomes.
Our research encompasses:
By combining experimental research with computational modeling and clinically relevant validation, BTC seeks to improve the efficiency of therapeutic discovery and support the progression of promising research findings toward preclinical evaluation, clinical investigation, and eventual healthcare applications.
An important component of this theme is the development of a strong translational research and innovation pipeline, connecting laboratory discoveries with clinical partners, healthcare institutions, industry collaborators, and commercialization opportunities. This includes supporting intellectual property development, patent applications, technology transfer, start-up creation, and investigator-led clinical research.
Through these activities, BTC aims to contribute to the development of more effective, targeted, accessible, and innovative diagnostic and therapeutic solutions.
This theme addresses the biological, clinical, environmental, and societal determinants of health across the lifespan, with particular emphasis on healthy aging, chronic disease prevention, and the promotion of population wellbeing.
By integrating epidemiology, genomics, biostatistics, digital health, clinical research, and population-based studies, our researchers investigate the complex interactions among genetic predisposition, lifestyle, environmental exposures, and social determinants of health.
Key research priorities include:
The theme also incorporates a One Health perspective, recognizing the interconnected relationships among human, animal, and environmental health. Through interdisciplinary research, surveillance, and preventive approaches, BTC seeks to contribute to the understanding of health risks arising from biological, environmental, and ecological interactions.
By generating population-relevant scientific evidence and collaborating with healthcare providers, government agencies, and public health stakeholders, this theme aims to inform preventive interventions, healthcare strategies, and policies that promote healthier communities and more sustainable health systems.
The three research themes are supported by an integrated ecosystem of scientific expertise, technological platforms, and shared research infrastructure.
BTC draws on capabilities in genomics and multi-omics technologies, molecular and cellular biology, biobanking, bioinformatics, advanced statistical modeling, artificial intelligence, high-performance computing, imaging, and clinical and translational research.
These capabilities enable researchers to investigate biological processes across multiple scales, from genes and molecules to cells, individuals, and populations. They also facilitate the integration of experimental, computational, and clinical approaches, supporting the development of innovative solutions to complex biomedical challenges.
Through access to institutional research facilities and collaboration with clinical and scientific partners, BTC promotes efficient use of resources, interdisciplinary research, and the generation of high-quality, reproducible scientific evidence.
An important strategic priority is the continued development of these capabilities into an increasingly integrated research and service ecosystem that can support collaborative projects, specialized scientific services, technology development, and knowledge exchange with external partners.
BTC is committed to ensuring that scientific excellence translates into measurable benefits for healthcare, society, and the broader innovation ecosystem.
Our research activities extend beyond scientific publications to encompass the development of intellectual property, innovative diagnostic and therapeutic technologies, clinical research initiatives, and opportunities for commercialization and entrepreneurship.
By connecting fundamental discoveries with technological development, clinical validation, and industry engagement, BTC seeks to accelerate the translation of promising scientific findings into practical applications.
The Center also supports the development of biotechnology ventures, technology-transfer opportunities, and research-driven entrepreneurial initiatives that can contribute to the growth of a knowledge-based economy.
Our long-term ambition is to strengthen BTC鈥檚 position as a research-driven Center of Excellence and regional biotechnology innovation hub, combining high-impact scientific research with translational partnerships, specialized services, professional education, and sustainable innovation activities.
Collaboration is central to BTC鈥檚 scientific mission and its ability to address complex challenges that require expertise across multiple disciplines and sectors.
The Center actively develops partnerships with leading academic institutions, hospitals, healthcare organizations, government agencies, research centers, and biotechnology and pharmaceutical companies, both within the UAE and internationally.
These collaborations provide opportunities to combine complementary expertise, access clinically relevant research environments, develop shared scientific infrastructure, undertake multidisciplinary research projects, and accelerate the translation of discoveries into healthcare applications.
Healthcare and public health partners
Partnerships with healthcare providers and public health organizations are particularly important for connecting scientific research with clinical needs, population health priorities, patient cohorts, and real-world healthcare challenges.
Academic partners
Academic collaborations strengthen international research networks, facilitate joint publications and research funding, and create opportunities for scientific exchange, advanced training, and collaborative postgraduate supervision.
Industry partners
Engagement with industry supports technology development, applied research, intellectual property generation, and the commercialization of innovative biotechnology solutions.
Through these activities, BTC seeks to establish sustainable, mutually beneficial partnerships that enhance scientific excellence, expand translational opportunities, and contribute to Khalifa University鈥檚 international research visibility and impact.
BTC recognizes that developing scientific talent is essential to building a sustainable biotechnology research and innovation ecosystem.
The Center is strongly committed to educating, mentoring, and training the next generation of researchers, scientists, clinicians, and biotechnology professionals through an integrated approach that combines academic excellence with practical research experience.
Our educational and training activities encompass:
Students and early-career researchers have opportunities to participate in active research projects, work alongside experienced investigators, and gain exposure to advanced experimental techniques, computational methodologies, clinical research processes, and emerging biotechnology applications.
By engaging trainees across the three research themes, BTC promotes interdisciplinary thinking and equips participants with the scientific, analytical, technical, and collaborative skills required to address increasingly complex biomedical challenges.
The Center also supports outreach initiatives that introduce school students and young researchers to biotechnology and scientific careers, helping build a continuous talent-development pathway from early scientific exposure to advanced research training.
Looking ahead, BTC aims to expand its professional development activities through specialized training programs, industry engagement, and continuing education opportunities that respond to the evolving needs of the biotechnology, healthcare, and life sciences sectors.
BTC鈥檚 research strategy supports Khalifa University鈥檚 commitment to scientific excellence, innovation, and meaningful contributions to the UAE鈥檚 knowledge-based economy.
By advancing precision medicine, innovative therapeutics, healthy aging, population health, and biotechnology-enabled solutions, the Center contributes to national priorities in healthcare innovation, advanced technology development, scientific capacity building, and sustainable development.
Our research also aligns with relevant United Nations Sustainable Development Goals, particularly those addressing good health and wellbeing, quality education, industry and innovation, partnerships, and environmental sustainability.
Through the integration of cutting-edge science, responsible innovation, interdisciplinary collaboration, and the development of future scientific leaders, BTC seeks to make a lasting contribution to the UAE and the international scientific community.
At the Center for Biotechnology, our ambition is to transform scientific discovery into better health, innovative technologies, stronger research capabilities, and lasting societal impact 鈥� advancing biotechnology for healthier people, healthier populations, and a more sustainable future.
To advance human health, precision medicine, and population wellbeing by integrating cutting-edge biotechnology, artificial intelligence, and translational research, transforming scientific discoveries into innovative solutions for disease prevention, diagnosis, and treatment.
The Center for Biotechnology pursues this mission through four strategic commitments: